RNA interference: the silent treatment.
Clayton
Julie
J
D000818:Animals; D001709:Biotechnology / Q000379:methods* / Q000639:trends*; D002477:Cells / Q000187:drug effects / Q000378:metabolism; D004194:Disease; D004195:Disease Models, Animal; D004337:Drug Carriers; D005818:Genetic Engineering / Q000379:methods*; D015316:Genetic Therapy; D005822:Genetic Vectors / Q000009:adverse effects / Q000235:genetics; D006801:Humans; D016376:Oligonucleotides, Antisense / Q000235:genetics / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D034622:RNA Interference; D016337:RNA, Catalytic / Q000235:genetics / Q000378:metabolism / Q000494:pharmacology; D034741:RNA, Small Interfering / Q000008:administration & dosage / Q000235:genetics / Q000494:pharmacology* / Q000627:therapeutic use; D015203:Reproducibility of Results; D013379:Substrate Specificity
D004337:Drug Carriers; D016376:Oligonucleotides, Antisense; D016337:RNA, Catalytic; D034741:RNA, Small Interfering